Insys Therapeutics Inc (NASDAQ:INSY) reported that SYNDROS™ has been made available for health care executives to prescribe. It is stocked with most of the key wholesalers...
AbbVie Inc (NYSE:ABBV) released financial report for the second quarter closed June 30, 2017. Richard A. Gonzalez, the CEO and Chairman, reported that they are delighted...
Vitality Biopharma Inc (OTCMKTS:VBIO) reported positive preclinical efficacy data for its gut-targeted cannabosides in the cure of colitis. The company has advanced a new class of...
Vitality Biopharma Inc (OTCMKTS:VBIO) reported that for each of the pharmaceutical offerings in their pipeline, the active Hemp pharmaceutical agents are either now in late-stage clinical...
For the year closed March 2017, Vitality Biopharma Inc (OTCMKTS:VBIO) reported revenue of $163,363 compared to revenue of $248,348 in the same period, a year ago....
AbbVie Inc (NYSE:ABBV) reported that the European CHMP of the European Medicines Agency has granted a promising opinion suggesting marketing approval of MAVIRET™, an investigational, pan-genotypic...
In the last trading session, the stock price of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) traded in a narrow range, only to close marginally in green. Latest...
Q BioMed Inc (OTCMKTS:QBIO) reported that Christopher Manuele will join commercialization team of the Strontium 89 Chloride. Manuele is a results-driven, innovative executive with 35 years...
Vitality Biopharma Inc (OTCMKTS:VBIO) a firm looking into the innovation of Hemps prodrug pharmaceuticals, and unveiling the usefulness of Hemps for the inflammatory and neurological problems,...
Latest R&D in the medical cannabis market is assisting industry leaders list breakthroughs and notable discoveries for advancing new patents and treatments for numerous applications aiming...
